ArticleJournal of the neurological sciences2022

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series.

Marcello Moccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.